ID 322970799 © Leo Rohmann | Dreamstime.com
dreamstime_xxl_322970799
Precision Medicine

NIH clinical trial will test precision medicine treatments for myeloid cancers

Oct. 29, 2024
Researchers will seek to accelerate the discovery of more tailored treatments for these aggressive cancers of the blood and bone marrow.
Photo © Kateryna Kon | Dreamstime.com
Dreamstime Xxl 132765369
Precision Medicine

Understanding sepsis: The importance of biomarkers in early diagnosis

It starts with a common infection leading to a chain reaction and deterioration of a person’s health. The symptoms are aggressive — including an accelerated heart rate, fever,...
https://stock.adobe.com/contributor/206152345/fokas-pokas?load_type=author&prev_url=detail
Adobe Test Tube Adobe Stock 433519890
Precision Medicine

‘Nanobodies’ could yield cell-specific medications

May 17, 2022
In “proof of concept” experiments, Johns Hopkins Medicine researchers say they have designed tiny proteins, called nanobodies, derived from llama antibodies, that could potentially...
https://pixabay.com/users/geralt-9301/
Pixabay Handshake 4608297 1280
Precision Medicine

Labcorp completes acquisition of Personal Genome Diagnostics

Feb. 22, 2022
Labcorp announced that it has closed its acquisition of Personal Genome Diagnostics (PGDx).PGDx has a portfolio of comprehensive liquid biopsy and tissue-based products. “The ...
Photo by CDC on Unsplash
Cdc Nm Zdj2 Zu36 M Unsplash
Precision Medicine

FDA approves NGS-based companion diagnostic for certain cases of non-small cell lung cancer

Dec. 10, 2021
Thermo Fisher Scientific said the U.S. Food and Drug Administration (FDA) has granted premarket approval to the company’s Oncomine Dx Target Test as a companion diagnostic to ...
Photo by Tara Winstead from Pexels
Pexels Tara Winstead 8384568
Precision Medicine

Foundation Medicine companion diagnostic garners FDA approval

Dec. 9, 2021
Foundation Medicine announced that it has received approval from the U.S. Food and Drug Administration (FDA) for FoundationOne CDx to be used as a companion diagnostic for two...
https://pixabay.com/users/gwen_30-2792362/
Ribbon Gd025842a9 1920
Precision Medicine

Young adults with cancer may need different treatments than older patients

Nov. 18, 2021
Young adults who are diagnosed with various types of cancer may require different treatments than older patients receive.That is the primary conclusion of a Mount Sinai study ...
Precision Medicine

Assay identifies patients with non small-cell lung cancer eligible for specialized therapy

Oct. 27, 2021
The U.S. Food and Drug Administration (FDA) has approved the use of the Roche's VENTANA PD-L1 (SP263) Assay in non-small cell lung cancer (NSCLC) as a companion diagnostic test...
Image by ChiemSeherin from Pixabay
Pigs 5240702 1920
Precision Medicine

Xenotransplantation provides access to new supply of much needed organs

Oct. 25, 2021
The first investigational transplant of a genetically engineered, nonhuman kidney to a human body was recently completed at NYU Langone Health—marking a major step forward in ...
Image by Raman Oza from Pixabay
Brain Black Purple Image By Raman Oza From Pixabay
Precision Medicine

Diuretic may be viable treatment for Alzheimer’s disease

Oct. 12, 2021
A commonly available oral diuretic pill approved by the U.S. Food and Drug Administration (FDA) may be a potential candidate for an Alzheimer’s disease treatment for those who...
Precision Medicine

Test assesses tumors in patients with rare disease

Sept. 3, 2021
Researchers from the National Cancer Institute’s (NCI) Center for Cancer Research, part of the National Institutes of Health (NIH), and Washington University School of Medicine...